Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose Projections. - Loughran HM; Schirripa KM; Roecker AJ; Breslin MJ; Tong L; Fillgrove KL; Kuo Y; Bleasby K; Collier H; Altman MD; Ford MC; Newman JA; et al. (ACS medicinal chemistry letters, 2023)